Advertisement
STE vs VREX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STE is a Hold and VREX is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
STE’s FA Score shows that 2 FA rating(s) are green whileVREX’s FA Score has 0 green FA rating(s).
- STE’s FA Score: 2 green, 3 red.
- VREX’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
STE’s TA Score shows that 4 TA indicator(s) are bullish while VREX’s TA Score has 4 bullish TA indicator(s).
- STE’s TA Score: 4 bullish, 6 bearish.
- VREX’s TA Score: 4 bullish, 5 bearish.
Price Growth
STE (@Medical/Nursing Services) experienced а -0.53% price change this week, while VREX (@Medical/Nursing Services) price change was -1.07% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.78%. For the same industry, the average monthly price growth was +2.20%, and the average quarterly price growth was +14.35%.
Reported Earning Dates
STE is expected to report earnings on Feb 04, 2026.
VREX is expected to report earnings on Feb 10, 2026.
Industries' Descriptions
@Medical/Nursing Services (-2.78% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| STE | VREX | STE / VREX | |
| Capitalization | 25.7B | 584M | 4,401% |
| EBITDA | 1.47B | 700K | 209,571% |
| Gain YTD | 3.215 | 19.571 | 16% |
| P/E Ratio | 37.49 | 19.08 | 196% |
| Revenue | 5.7B | 845M | 675% |
| Total Cash | 319M | 155M | 206% |
| Total Debt | 2.06B | 396M | 520% |
STE | VREX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 13 | 73 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 20 Undervalued | 82 Overvalued | |
PROFIT vs RISK RATING 1..100 | 53 | 100 | |
SMR RATING 1..100 | 70 | 95 | |
PRICE GROWTH RATING 1..100 | 21 | 39 | |
P/E GROWTH RATING 1..100 | 49 | 42 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
STE's Valuation (20) in the Medical Specialties industry is somewhat better than the same rating for VREX (82). This means that STE’s stock grew somewhat faster than VREX’s over the last 12 months.
STE's Profit vs Risk Rating (53) in the Medical Specialties industry is somewhat better than the same rating for VREX (100). This means that STE’s stock grew somewhat faster than VREX’s over the last 12 months.
STE's SMR Rating (70) in the Medical Specialties industry is in the same range as VREX (95). This means that STE’s stock grew similarly to VREX’s over the last 12 months.
STE's Price Growth Rating (21) in the Medical Specialties industry is in the same range as VREX (39). This means that STE’s stock grew similarly to VREX’s over the last 12 months.
VREX's P/E Growth Rating (42) in the Medical Specialties industry is in the same range as STE (49). This means that VREX’s stock grew similarly to STE’s over the last 12 months.
| STE | VREX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 50% | 1 day ago 76% |
| Stochastic ODDS (%) | 1 day ago 56% | 1 day ago 76% |
| Momentum ODDS (%) | 1 day ago 59% | 1 day ago 70% |
| MACD ODDS (%) | 1 day ago 49% | 1 day ago 64% |
| TrendWeek ODDS (%) | 1 day ago 53% | 1 day ago 74% |
| TrendMonth ODDS (%) | 1 day ago 51% | 1 day ago 65% |
| Advances ODDS (%) | 3 days ago 54% | 9 days ago 64% |
| Declines ODDS (%) | 8 days ago 50% | 6 days ago 74% |
| BollingerBands ODDS (%) | 1 day ago 64% | 1 day ago 75% |
| Aroon ODDS (%) | 1 day ago 37% | 1 day ago 58% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AVEE | 66.20 | 0.43 | +0.66% |
| Avantis Emerging Markets Sm Cp Eq ETF | |||
| APOC | 26.32 | -0.04 | -0.16% |
| Innovator Eq Dfnd Prt ETF - 6 Mo Apr/Oct | |||
| GPIQ | 52.43 | -0.72 | -1.35% |
| Goldman Sachs Nasdaq-100 Premium Inc ETF | |||
| BWEB | 66.93 | -1.38 | -2.02% |
| Bitwise Web3 ETF | |||
| CONL | 8.89 | -0.86 | -8.82% |
| GraniteShares 2x Long COIN Daily ETF | |||
STE and
Correlation & Price change
A.I.dvisor indicates that over the last year, STE has been loosely correlated with SYK. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if STE jumps, then SYK could also see price increases.
VREX and
Correlation & Price change
A.I.dvisor indicates that over the last year, VREX has been loosely correlated with GMED. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VREX jumps, then GMED could also see price increases.
| Ticker / NAME | Correlation To VREX | 1D Price Change % | ||
|---|---|---|---|---|
| VREX | 100% | -1.62% | ||
| GMED - VREX | 59% Loosely correlated | -2.51% | ||
| GEHC - VREX | 51% Loosely correlated | -1.66% | ||
| NVST - VREX | 51% Loosely correlated | -1.50% | ||
| ENOV - VREX | 49% Loosely correlated | -1.71% | ||
| SYK - VREX | 47% Loosely correlated | -1.99% | ||
More | ||||